CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
GORE TAG® Thoracic Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00590759
NCT00590759N/ACompleted
CompareCT.gov

A Clinical Evaluation of the GORE TAG Thoracic Endoprosthesis in the Primary Treatment of Descending Thoracic Aortic Aneurysms

W.L.Gore & Associates·interventional·Posted Jan 11, 2008·Updated Aug 7, 2014

In Brief

A clinical study evaluating GORE TAG® Thoracic Endoprosthesis for Aortic Aneurysm, Thoracic. Completed, enrolled 150 participants across 25 sites.

Detailed Summary

The purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending thoracic aortic (DTA) aneurysms

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm, Thoracic
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 11, 2008
Enrollment StartAug 1, 2005
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7.7 yearsPosted 18.5 years ago

Interventions

GORE TAG® Thoracic Endoprosthesisdevice

implant